Omega-3 Index Testing in Cardiovascular Risk Assessment
Blood tests reveal most Americans lack omega-3 levels needed to prevent heart disease.
Nnamdi Oduya
Columnist
Nnamdi Oduya
Nnamdi Oduya covers advanced biomarker panels and longitudinal lab testing, whole-genome sequencing and genetic risk interpretation and features for The Baseline Panel.
4 stories
ApoB vs LDL-C as a Cardiovascular Risk Biomarker
Particle count, not cholesterol mass, better predicts heart attack and stroke risk.
Nnamdi Oduya
Germline vs Somatic Variants in Preventive Genomic Screening
Understanding which variants are inherited versus acquired shapes every screening decision.
Nnamdi Oduya
Reading an advanced biomarker panel: which markers earn a repeat draw
Learn which abnormal biomarkers deserve a repeat test before you act.
Nnamdi Oduya